Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 121,600 | 107,190 | 58,344 | 14,859 | 40,133 |
| Gross Profit | 121,600 | 107,190 | 58,344 | 14,859 | 40,133 |
| Operating Expenses | 149,138 | 120,250 | 91,263 | 80,077 | 97,315 |
| Operating Income | -27,538 | -13,060 | -32,919 | -65,218 | -57,182 |
| Interest Expense | 12,672 | 11,812 | 12,872 | 9,029 | 20,313 |
| Other Income | 8,445 | 10,353 | 11,741 | 31,244 | 5,094 |
| Pre-tax Income | -31,765 | -14,519 | -34,050 | -43,003 | -72,401 |
| Income Tax | 3,191 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -34,956 | -14,519 | -34,050 | -43,003 | -72,401 |
| Net Income Discontinuous | 185,628 | -8,387 | -6,029 | -2,900 | N/A |
| Minority Interests | -4,394 | -4,734 | -23,786 | N/A | N/A |
| Net Income | $155,066 | $-18,172 | $-16,293 | $-45,903 | $-72,401 |
| EPS Basic Total Ops | 1.58 | -0.19 | -1.69 | -0.62 | -1.15 |
| EPS Basic Continuous Ops | -0.31 | -0.10 | -0.41 | -0.58 | -1.15 |
| EPS Basic Discontinuous Ops | 1.89 | -0.09 | -0.07 | -0.04 | N/A |
| EPS Diluted Total Ops | 1.58 | -0.19 | -1.69 | -0.62 | -1.15 |
| EPS Diluted Continuous Ops | -0.31 | -0.10 | -0.41 | -0.58 | -1.15 |
| EPS Diluted Discontinuous Ops | 1.89 | -0.09 | -0.07 | -0.04 | N/A |
| EBITDA(a) | $-8,595 | $538 | $-20,855 | $-57,399 | $-46,194 |